|
|
|
Volumn 24, Issue 6 SUPPL. 19, 1997, Pages
|
|
The pharmacoeconomics of cancer therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
METHOTREXATE;
MITOMYCIN;
PACLITAXEL;
PREDNISONE;
ADVANCED CANCER;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER SURVIVAL;
COST BENEFIT ANALYSIS;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
HEALTH CARE COST;
LUNG NON SMALL CELL CANCER;
OVARY CANCER;
PRIORITY JOURNAL;
QUALITY OF LIFE;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
NEOPLASMS;
OVARIAN NEOPLASMS;
PACLITAXEL;
QUALITY OF LIFE;
|
|
EID: 0031473914
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (33)
|
